15-Avp-786-301
Research payments
$1,692,509
Through program year 2020, $1,692,509 in research payments was reported against 15-Avp-786-301, across 209 payments, paid by Avanir Pharmaceuticals, Inc..
- Paid by
- Avanir Pharmaceuticals, Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | Research | $13,965 | 4 |
| 2019 | Research | $1,678,543 | 205 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Laurence Radin New London, CT Named on 10 payments
- Mehrdad Mahdad Fountain Valley, CA Named on 7 payments
- Daniel Chueh Orange, CA Named on 6 payments
- Orlando Rodriguez Miami, FL Named on 6 payments
- Manuel Fernandez Miami, FL Named on 6 payments
- Yaneicy Gonzalez Rojas Coral Gables, FL Named on 5 payments
- Kelly Yokum Tampa, FL Named on 5 payments
- Inna Yuryev-Golger Brooklyn, NY Named on 5 payments
- Leonardo Alonso Miami, FL Named on 5 payments
- Hugo Llanes Miami, FL Named on 5 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.